August 23, 2016


Internal Advisory Board

Julia Bynum, MD, MPH (Chair) - University of Michigan

Julie Bynum, M.D., M.P.H., Professor of Internal Medicine, Division of Geriatric & Palliative Medicine, earned her BS from Union College, an MPH from The Johns Hopkins School of Hygiene & Public Health, and an MD from Johns Hopkins University School of Medicine. One of Bynum’s contributions to the field has been to develop a method of creating “virtual” physician-hospital networks that allows the measurement of care delivered and its outcomes for a population served by a specific group of providers. These networks were used in the conceptual development of the Accountable Care Organization(ACO) legislation. Dr. Bynum joins us from The Dartmouth Institute for Health Policy & Clinical Practice (TDI), Geisel Medical School at Dartmouth, Lebanon, NH.

Toni Antonucci, PhD - University of Michigan

Dr. Toni Antonucci is the Elizabeth M. Douvan Collegiate Professor of Psychology in the University of Michigan Department of Psychology and a Senior Research Scientist at the U-M Institute of Social Research Life Course. Her research focuses on social relations and health across the life span, including multigenerational studies of the family and comparative studies of social relations across the life span in the United States, Europe and Japan. We are currently collecting a second wave of data on the Social Relations and Health across the Life Span study. She also co-leads the Michigan Center for Contextual Factors in Alzheimer's Disease (MCCFAD) which focuses on the education and enrollment into dementia research for Arab Americans and Hispanics.

F. DuBois Bowman, PhD - University of Michigan

Dr. Bowman is the Dean of the School of Public Health. He earned a B.S. degree in mathematics from Morehouse College, where he was a member of the Phi Beta Kappa honor society. He earned a master's in biostatistics from the University of Michigan, and a PhD in biostatistics from the University of North Carolina, Chapel Hill. Dr. Bowman's areas of study include Parkinson's disease, Alzheimer's disease, depression, schizophrenia, and substance addiction. His research has helped to reveal brain patterns that reflect disruption from psychiatric diseases, detect biomarkers for neurological diseases, and determine more individualized therapeutic treatments. Additionally, his work seeks to determine threats to brain health from environmental exposures and to optimize brain health in aging populations.

Jack Lipton, PhD - Michigan State University

Jack W. Lipton, PhD is the Chair and Professor of Translational Neuroscience at Michigan State University in Grand Rapids. He received his undergraduate degree from the University of California, Berkeley in 1988 in Psychology. He went on to earn his PhD in Behavioral Neuroscience at UCLA in 1993 with Dr. Michael J. Fanselow. After finishing a postdoctoral fellowship at Rush Children's Hospital in Chicago with Dr. Paul M. Carvey, Dr. Lipton was offered an assistant professorship at Rush University Medical Center (RUMC) in the Department of Pharmacology in 1996 where he established a research program examining the consequences of fetal exposure to cocaine and ecstasy on the developing brain. He was promoted to Associate Professor of Neurological Sciences in 2002. In 2004, Dr. Lipton and a team of his colleagues from RUMC relocated to the University of Cincinnati (UC). He was promoted to full professor in 2004 and became the Director of the Division of Neuropharmacology in the Department of Psychiatry. Dr. Lipton joined the MSU College of Human Medicine in July of 2009 and is currently Chair of the Department of Translational Neuroscience. Dr. Lipton and his colleagues Dr. Timothy Collier, Dr. Kathy Steece-Collier and Dr. Caryl Sortwell, have been designated a Udall Center of Excellence for Parkinson’s Disease Research. Dr. Lipton has been continuously funded by the NIH since 1993 through the National Institute on Drug Abuse, the National Institute on Neurological Disorders and Stroke and the Michael J. Fox Foundation. He is the author of over 50 papers and book chapters on the pharmacology and toxicology of drugs of abuse and the neurobiology of Parkinson's disease. In his spare time, he can often be found tinkering on old motorcycles in his backyard.

Donovan Maust, MD, MS - University of Michigan

Donovan T. Maust, M.D., M.S., is a geriatric psychiatrist and health services researcher. He has two primary areas of research interest. First, he is interested in understanding both the drivers and consequences of potentially inappropriate psychotropic use among older adults, focusing on benzodiazepines and antipsychotics. In addition, his research explores the factors that drive the potentially inappropriate healthcare utilization of patients with dementia.

Dr. Maust earned his medical degree from Johns Hopkins University. He completed his psychiatry residency and geriatric psychiatry fellowship at the University of Pennsylvania, with further training in health services research at the University of Michigan. He is an assistant professor in the Department of Psychiatry and a research scientist in the Center for Clinical Management Research of the VA Ann Arbor Healthcare System.

Keith Whitfield, PhD - Wayne State University

Keith E. Whitfield became provost of Wayne State University on June 1, 2016. Previously, he was vice provost for academic affairs at Duke University, and held appointments as professor in the Department of Psychology and Neuroscience, research professor in the Department of Geriatric Medicine at Duke University Medical Center, and senior fellow at the Center for the Study of Aging and Human Development. He also was the co-director of the Center on Biobehavioral Health Disparities Research.

An expert on aging among African Americans, Dr. Whitfield has published 200 articles, books and book chapters on cognition, health, and individual development and aging. He is a longtime member of the advisory board of Wayne State’s Institute on Gerontology, has participated in a number of committees for the National Academies of Sciences and Medicine, and has served on several study sections for the National Institutes of Health.

Dr. Whitfield earned a bachelor’s in psychology from the College of Santa Fe, a PhD in lifespan developmental psychology from Texas Tech University, and received postdoctoral training in quantitative genetics from the University of Colorado Boulder.

Darlene K. Racz, MSW, LMSW

University of Michigan

Ms. Racz has worked in community-based adarlene-leadershipging and human services programs for more than 30 years. She is a licensed social worker whose special interests include aging and consultation on caring for an aging relative. She holds a specialist in aging certificate and a post-M.S.W. certificate in human services management, both from the University of Michigan. Ms. Racz is a member of the National Association of Social Workers and the Academy of Certified Social Workers since May 1982, Advanced Social Worker in Gerontology since March 2007. She is a former member of the Detroit Area Agency on Aging Advisory Counsel. She has presented on a number of aging-related topics for the National Counseling on Aging, and is a past elected delegate to the Michigan White House Conference on Aging.

Donna McDonald, BA

Wayne State University

donnaDonna began working at the Institute of Gerontology in May of 2006. Currently she is the Director of Community Outreach and Professional Development  for the Institute. Donna provides direction for the Art of Aging Conference, Issues in Aging Conference, Speaker’s Bureau, Windows on the World of Aging, HBE learning series and the Healthier Black Elder’s Health Reception.  The Institute is now offering several continuing education opportunities that Donna is at the helm of as well.   Her primary focus is to educate the senior population in a wide variety of topics, from Alzheimer’s Research to Creative Aging Techniques and everything in between. The outreach department feels it is imperative to bring our research to the forefront and arm seniors with the necessary information for them to make informed decisions about their futures and their health care needs. Donna has the ability to interact with the aging population in a positive and respectful manner, realizing they are the key to the health and longevity of future generations.

Jennifer Howard, MSW

Alzheimer’s Association Great Lakes Chapter


Jennifer Howard has served as the Executive Director of the Alzheimer’s Association, Michigan Great Lakes Chapter for the past four years but has been involved with the Association for about 15 years as a volunteer and staff member. Her current responsibilities include oversight of the care and support of over 55,000 individuals in Michigan with dementia, fundraising activities for the organization and oversight of all public policy efforts in Michigan. Jennifer has worked with state legislators to introduce, pass and implement legislation to benefit those in Michigan with dementia. She has participated in and lead volunteers through two national advocacy forums in Washington D.C. for the Alzheimer’s Association. Jennifer’s education includes a BA in Psychology from Wayne State University in Detroit, MI and a Master’s Degree in Social Work with a focus on gerontology, clinical practice and community organization from the University of Michigan in Ann Arbor. Prior to working for the Alzheimer’s Association, Jennifer served as a clinical social worker for Turner Geriatric Clinic at the University of Michigan. Her work there included patient assessment, family and individual counseling, family mediation, patient education, grant writing, student education and mentoring, care management and support group facilitation.

Keri Sederburg, MPA

Michigan Department of Health and Human Services


Keri Sederburg is executive director for the Aging and Adult Services Agency at the Michigan Department of Health and Human Services.In that role, she serves as the chief advocate for more than 2 million older adults in Michigan, directing nearly $100 million in federal and state funding for aging programs and helping to shape policies that provide older adults the services they need.  Previously, she served as director of the Office of Services to the Aging, a position to which Gov. Rick Snyder appointed her in 2011.  She also has served as director of public policy for the Michigan Nonprofit Association, vice president for marketing and communications at the Gerontology Network in Grand Rapids, a senior account executive at The Rossman Group and as program officer for the Detroit Local Initiatives Support Corporation.

Kevin Foley, MD, FACP

Michigan State University


Dr. Foley is director of academic and clinical operations in geriatrics in the Department of Family Medicine. His primary role is to be the academic leader of geriatric medicine at MSU. He also holds a secondary appointment in the CHM Department of Medicine. His key responsibilities include developing a statewide network of fellowship programs in geriatric medicine in affiliation with existing MSU Family Medicine residency training programs; assuming directorship of one of the fellowship training programs, at Sparrow hospital; teaching geriatric medicine to residents in the colleges of Human Medicine and Osteopathic Medicine; and instructing medical students. In addition to providing clinical care at the Sparrow Geriatric Health Center, he serves as medical director of the Alzheimer’s Disease and Memory Disorders Service in the neuroscience department at Saint Mary’s Health Care in Grand Rapids.Dr. Foley completed his residency in internal medicine and a fellowship in geriatric medicine at the University of Michigan. He was formerly a staff geriatrician at the Cleveland Clinic.

Salli Bollin, MSW

Alzheimer’s Association Northwest Ohio Chapter

salli_bollin_webSalli Bollin, MSW, is the Executive Director of the Northwest Ohio Chapter of the Alzheimer’s Association, serving 24 counties. As executive director, Ms. Bollin is responsible for strategic planning, program development, and public policy activities at local, state and federal levels. Ms. Bollin also is an Adjunct Instructor in Gerontology at Bowling Green State University and received a Master’s in Social Work from the University of Michigan.

Alan Dengiz, MD

Geriatrics Center, Clinical Assistant Professor, UMHS

dengizA geriatrician in the Geriatrics Center, Dr. Dengiz has long been interested in dementing disorders.  He has participated in clinical trials for Alzheimer’s disease and enjoys lecturing to health care professionals and the lay public on age-related diseases affecting the brain.

MADC Consultants

Neil Alexander, MD, MS - University of Michigan

Dr. Alexander graduated from the University of Minnesota Medical School, Minneapolis and received a clinical research design and biostatistics master’s degree from University of Michigan. He completed his internal medicine residency at the University of New Mexico Affiliated Hospitals and a geriatrics fellowship at the University of Michigan. He is a past research fellow at the University of Michigan Institute of Gerontology. Dr. Alexander is board-certified in internal medicine and geriatrics. He has a special interest in exercise, mobility, falls and rehabilitation in older adults. He is the Director of the VA Ann Arbor Geriatric Research Education and Clinical Center.

Sami Barmada, MD, PhD - University of Michigan

Dr. Barmada received his PhD in the Medical Scientist Training Program at Washington University in St. Louis, where he investigated prion diseases with Dr. David Harris, now chair of Biochemistry at Boston University. His neurology residency, at the University of California, San Francisco (UCSF), gave him the opportunity to train with some of the premier clinicians and scientists in neurodegenerative diseases, including Dr. Bruce Miller, head of the UCSF Memory and Aging Center, and Dr. Cathy Lomen-Hoerth, Director of the UCSF ALS Center. During residency and continuing in a postdoctoral fellowship, he worked with Dr. Steve Finkbeiner at the Gladstone Institutes in San Francisco, where he established faithful model systems for the study of ALS and FTD pathogenesis, including one of the first human neuronal models of familial ALS and FTD. Dr. Barmada arrived at the University of Michigan as an Assistant Professor of Neurology in 2013, and was promoted to Associate Professor in 2020.

Dr. Barmada’s research takes advantage of a broad toolkit of innovative technologies and methods involving fluorescence microscopy, computer science and engineering, bioinformatics, genome engineering and molecular biology to investigate important yet unanswered questions in neurodegenerative diseases. His work, centering on critical abnormalities in RNA and protein metabolism in ALS and FTD, combines basic biology with translational research and technology development. Dr. Barmada serves on the executive advisory board of the Robert Packard Center for ALS Research, and acts on the scientific advisory boards of the Live Like Lou Foundation and Synapticure, Inc. He has taken an active role in their efforts to raise awareness of ALS in the community, and participates in several local and national fundraising efforts. In recognition of the impact and promise of his original research, Dr. Barmada was awarded the Young Physician Scientist Award from the American Society for Clinical Investigation in 2014, and he received the distinguished Angela Dobson and Lyndon Welch Research Professorship at the University of Michigan in 2015.

Andrew Bender, PhD - Michigan State University

Dr. Bender earned his Ph.D. in Behavioral and Cognitive Neuroscience from the Department of Psychology at Wayne State University in 2014, followed by a year-long postdoctoral appointment with the Institute of Gerontology. In 2018, he completed a three-year postdoctoral fellowship in Lifespan Development at the Max Planck Institute for Human Development in Berlin, Germany, before joining the departments of Epidemiology-Biostatistics and Neurology-Ophthalmology at MSU. Trained as a cognitive neuroscientist, with a broad focus on lifespan development and aging, quantitative methods, Dr. Bender’s work seeks to understand how individual differences in vascular, metabolic, and lifestyle risk factors contribute to changes in the brain’s structure and function in normal aging and in dementia.

Charles Burant, MD, PhD - University of Michigan

Dr. Burant directs a research program that integrates molecular phenotyping (including metabolomics) with dietary, clinical and behavioral phenotypes to understand the development of obesity, insulin resistance and diabetes. He has a specific interest in intermediary metabolism and he has integrated metabolomics with other technologies to gain a more complete understanding of cellular metabolism. Dr. Burant directs the Michigan Regional Comprehensive Metabolomics Resource Core (U24), which is one of six NIH-funded metabolomics centers. At the MADC, he provides advice on the use of metabolomics profiling to gain insights into the pathophysiology of neurodegenerative diseases and the potential relationship to metabolic syndrome, obesity, diabetes and other metabolic states.

David Burke, PhD - University of Michigan

David Burke, PhD, is a Professor of Human Genetics and a Clinical Core Consultant for the MADC. His research interests include the development of low cost, single nucleotide variant DNA and RNA testing methods which are employed by the MADC in genetic risk factor assessment. The robust methods are currently used in the laboratory to perform over ten thousand human, mouse, viral and bacterial SNP genotypes per year.

Benjamin Combs, PhD - Michigan State University

Dr. Benjamin Combs is a Research Assistant Professor of Translation Science & Molecular Medicine in the Kanaan Lab at Michigan State University. He was also a past junior investigator mentee in our Research Education Component.

Scott Counts, PhD - Michigan State University

Scott grew up in Virginia and South Carolina and received his undergraduate degree from Davidson College, concentrating in History and English. After working for several years as a chemist at the U.S. Centers for Disease Control, he went on to earn his Ph.D. in Neuroscience from Emory University in 2000, studying under Dr. Allan I. Levey in the Department of Neurology to understand the metabolic regulation of presenilin-1, a key protein involved in familial forms of Alzheimer’s Disease (AD). That same year, he joined Dr. Elliott J. Mufson’s lab at Rush University Medical Center as an Instructor of Neurological Sciences, studying cholinergic mechanisms of AD and its prodromal stage, mild cognitive impairment (MCI), as part of Rush’s NIA-funded Training Program in Age-related Neurodegenerative Disorders. Dr. Counts was appointed to an Assistant Professor of Neurological Sciences at Rush in 2003 based on his expertise in using functional genomic technologies to compare and contrast postmortem brain samples from people who died within the clinical spectrum of no cognitive impairment (NCI) to MCI to AD. In 2013, Dr. Counts was recruited to Michigan State University as an Associate Professor of Translational Neuroscience (primary) and Family Medicine (secondary) at the Grand Rapids campus. His research has been continuously funded since 1998 and he is an author of over 75 papers and book chapters on the molecular pathogenesis of dementia. When not in the lab, Scott has enjoyed exploring Grand Rapids and western Michigan with his family.

Jessica Damoiseaux, PhD - Wayne State University

Jessica Damoiseaux, PhD, is an Associate Professor in the Institute of Gerontology and the Department of Psychology. Dr. Damoiseaux' main research goal is to understand the changes in brain function and cognition that accompany normal and abnormal aging. She is particularly interested in examining the influence of biological and cognitive predisposition on cognitive and brain network connectivity changes in healthy older adults. The primary approach Dr. Damoiseaux uses to study brain network connectivity is functional magnetic resonance imaging (fMRI). In addition, she uses other neuroimaging techniques, such as structural MRI and diffusion imaging to study brain structure and structural brain connectivity.

Ana Daugherty, PhD - Wayne State University

Dr. Daugherty directs the Healthy Brain Aging Laboratory that studies health factors and behaviors that shape changes in brain structures and functions across the lifespan. She has a particular interest in metabolic and vascular health, and studies both risk (e.g., hypertension, metabolic syndrome) and protective (e.g., aerobic exercise) factors. Towards this end, her studies include measures of brain structure from MRI, cognitive ability, blood serum biomarkers, genetics, and lifestyle behaviors. She works with adults of all ages, and in collaboration with other laboratories at the IOG, she studies the breadth of the human lifespan from childhood to late adulthood.

Sean Ferris, PhD - University of Michigan

Dr. Sean Ferris is an Assistant Professor in the Department of Pathology and Division of Neuropathology at the University of Michigan. Dr. Ferris received his AB from Brown University and his MD/PhD from the University of Michigan Medical School. He completed residency training in Anatomic Pathology and fellowship training in Neuropathology at the University of California San Francisco.

At University of Michigan, Dr. Ferris serves on the clinical surgical neuropathology, muscle and nerve, and Alzheimer's Disease Research Center (ADRC) autopsy services.

Luis Hernandez-Garcia, PhD - University of Michigan

Dr. Hernandez's research interests are focused on developing and integrating techniques for the study of brain function.

He has been involved in BOLD (Blood Oxygenation Level Dependent) and ASL (Arterial Spin Labeling) Functional MRI research for a number of years. Primarily, he has been developing ASL methods for quantitatively imaging cerebral perfusion. Perfusion is an indicator of brain function and therefore a very valuable tool, not just for the clinician, but also for the neuroscientist and psychologist. He is currently working on kinetic models for quantifying the ASL signal, and techniques that will improve the SNR and temporal resolution of perfusion measurements.

Dr. Hernandez is also working on developing methods for non-invasive brain stimulation techniques. He has worked on the design and analysis of transcranial magnetic stimulation (TMS) devices, and is also active in the development of focused ultrasound neuromodulation technology.

Finally, he has collaborated tightly with research groups in psychology and neurology in the study of attention, memory, pain and depression.

Kevin Jones, PhD - Central Michigan University

Dr. Jones received his PhD from Duke University Medical School and completed a Postdoctoral Fellowship at the Ramon y Cajal Institute, Department of Neural Plasticity in Madrid, Spain. He was also an Assistant Professor at Western University of Health Sciences, College of Osteopathic Medicine of the Pacific, Department of Basic Medical Sciences and a Postdoctoral Fellow at the Center for Neuroscience in the Children’s Research Institute, Wash, DC. He is currently an Assistant Professor of Biology at Howard University in Washington, DC.

The goal of the Jones Lab is to identify novel therapeutic approaches to improve iGluR dysfunction. Dysfunctional neurotransmission through iGluRs contribute to the pathophysiology of many psychiatric and neurological disorders. Recent evidence suggests expression of the iGluR subunit, GluA4, may be dramatically reduced in Alzheimer's Disease (AD) patients (Xiao et al., 2017). The Jones lab is interested in replicating the findings of Xiao et al. Specifically, they wish to compare the expression of GluA4 in tissue samples of controls and AD patients from the University of Michigan Brain Bank.

Lenette Jones, PhD, RN - University of Michigan

Dr. Jones is a behavioral nurse scientist interested in eliminating the health disparities affecting African-American women with hypertension. Her program of research is focused on uncovering the mechanisms – biological, psychological, social, and physical – of self-management interventions. She uses neuroimaging (fMRI) to explore the neuroprocesses associated with self-management behaviors, such as diet, exercise, and medication-taking. She also examines how health information behavior (seeking, sharing, and use) can be enhanced to support blood pressure self-management. In her current studies, Dr. Jones is designing and pilot-testing interventions to improve self-management of blood pressure among African American women.

Jian Kang, PhD - University of Michigan

Jian Kang is a Professor in the Department of Biostatistics and is a faculty member of the Kidney Epidemiology and Cost Center (KECC) at the University of Michigan.  He received his PhD in Biostatistics from the University of Michigan in 2011. He was an Assistant Professor in the Department of Biostatistics and Bioinformatics and the Department of Radiology and Imaging Sciences at Emory University from 2011 - 2015. He was a core faculty member in the Center for Biomedical Imaging Statistics (CBIS) at Emory University.  His primary research interests are in developing statistical methods for large-scale complex biomedical data with application in precision medicine, imaging, epidemiology and genetics.

Robert Koeppe, PhD - University of Michigan

Dr. Koeppe is a Professor of Radiology at the University of Michigan and the Director of the PET Physics Section of the Division of Nuclear Medicine. His research interests center around the quantitative aspects of positron emission tomography (PET). Specific research areas include the development and implementation of tracer kinetic models for new and existing positron labeled radiotracers, development of optimal techniques for estimation of physiological quantities, and development and implementation of automated image analysis routines for use with PET. Another specific area of research is the use of PET cerebral blood flow activation studies to examine various cognitive and neurological functions of the brain. Other research interests include the correlation and comparison of information obtained from PET studies to that obtained from corresponding anatomic imaging procedures such as magnetic resonance imaging.

Kenneth Langa, MD, PhD - University of Michigan

Dr. Langa is a Professor in the Department of Internal Medicine and Institute for Social Research, a Research Scientist in the Veterans Affairs Center for Clinical Management Research, and an Associate Director of the Institute of Gerontology, all at the University of Michigan. He is also Associate Director of the Health and Retirement Study (HRS), a National Institute on Aging funded longitudinal study of 25,000 adults in the United States.

Dr. Langa received an MD and PhD in Public Policy at the University of Chicago as a Fellow in the Pew Program for Medicine, Arts, and the Social Sciences. He is a board-certified General Internist with an active clinical practice treating adult patients, and he is an elected member of the American Society for Clinical Investigation (ASCI).

Dr. Langa’s research focuses on the epidemiology and costs of chronic disease in older adults, with an emphasis on Alzheimer’s disease and other dementias. He has published more than 175 peer-reviewed articles on these topics. He is currently studying population trends in dementia prevalence, and the relationship of common cardiovascular risk factors, as well as acute illnesses such as sepsis and stroke, to cognitive decline and dementia. In 2007 and 2015, Dr. Langa was a Visiting Professor at the Institute of Public Health at the University of Cambridge, and in 2015 he was also a Visiting Professor at the World Health Organization in Geneva, Switzerland, where he continued work on cross-national comparisons of the epidemiology and outcomes of dementia in the United States, England, and other countries around the world.

Amanda Leggett, PhD - University of Michigan

Dr. Leggett is a Research Assistant Professor in the Department of Psychiatry at the University of Michigan. Dr. Leggett’s research focuses on the development of a taxonomy of dementia caregiving care management styles and determining how style might be used to target interventions and optimize care. She is also interested in depression and sleep problems in caregivers and older adults more broadly.

Deborah Levine, MD, MPH - University of Michigan

Dr. Levine’s research aims to improve the lives and care of adults with chronic disease. Primary research interests are the epidemiology, prevention, and care of stroke and cognitive impairment, with a focus on vascular risk factors, adherence, and health disparities. Her research includes improving the quality of stroke care; stroke-related dementia and cognitive impairment; and reducing healthcare disparities in cardiovascular disease and stroke. She also focuses on quality improvement program design, implementation and evaluation research, and research on provider behavior. Some of her research is examining cognitive outcomes after stroke, seeking to understand the predictors and long-term trajectory of cognitive decline after stroke.

Jon-Fredrik Nielsen, PhD - University of Michigan

Dr. Nielsen is an Associate Research Scientist at the University of Michigan Department of Biomedical Engineering. His research focuses on Biomedical Imaging.

Gulin Oz, PhD - University of Minnesota

Dr. Gülin Öz is an associate professor in the Department of Radiology who specializes in magnetic resonance spectroscopy (MRS). Dr. Oz graduated from Bosphorus University in Istanbul, Turkey with BS degrees in Physics and Chemistry and obtained her PhD in Biochemistry at the University of Minnesota. She continued with postdoctoral training at the Center for Magnetic Resonance Research (CMRR) where she joined the faculty as assistant professor in 2006. Here she also served as the MR Core Director of the General Clinical Research Center (GCRC) from 2005-2009.

Scott Peltier, PhD - University of Michigan

Dr. Peltier's research deals with functional MRI data acquisition and analysis. Current areas of interest include: 1) resting-state functional connectivity; 2) real-time fMRI; 3) multivariate and data-driven analysis techniques; and 4) multimodal imaging. Dr. Peltier is the Technical Director of the Functional MRI Laboratory at the University of Michigan and a Research Scientist in the Department of Biomedical Engineering.

Courtney Polenick, PhD - University of Michigan

Courtney A. Polenick, Ph.D., is Assistant Professor in the Department of Psychiatry and Faculty Associate in the Aging & Biopsychosocial Innovations Program of the Survey Research Center at the U-M Institute for Social Research. Dr. Polenick’s research focuses on later-life family relationships and caregiving in the context of complex care needs including dementia and multimorbidity. She is particularly interested in understanding mutual influences within older couples managing chronic conditions that inform targeted dyadic interventions to maintain the well-being of both partners.

Sheria Robinson-Lane, PhD, RN - University of Michigan

Dr. Sheria Robinson-Lane is a gerontologist with expertise in palliative care, long-term care, and nursing administration. She has focused her career on the care and support of older adults with cognitive and/or functional disabilities. Dr. Robinson-Lane is interested in the ways that older adults adapt to changes in health, and particularly how adaptive coping strategies effect health outcomes. Her research is focused on reducing health disparities for minority older adults with cognitive impairments and their informal caregivers. Prior to coming to coming to the University of Michigan School of Nursing, Dr. Robinson-Lane completed an NIH-funded advanced research rehabilitation training program in community living and participation with the University of Michigan Medical School.

Navid Seraji-Bozorgzad, MD - University of Michigan

Navid Seraji-Bozorgzad, MD, is an associate professor of neurology in the University of Michigan Medical School.

Dr. Seraji-Bozorgzad began work in the area of medical imaging in 1990 as a research assistant during his undergraduate studies at the University of Michigan. He became familiar and developed a fundamental understanding of image acquisition and processing from his work on solid-state imaging arrays. After undergraduate work, he worked in the private sector as a software engineer, designing databases for various companies, including Ford Motor Company, and Liberty Mutual Insurance. The work provided him with experience in data-mining and manipulation of large datasets.

His passion for medicine eventually led him to medical school. During the application process he worked in the Department of Psychiatry and Behavioral Neurosciences, and eventually enrolled in graduate school in neuroscience. While in the Department of Psychiatry, he participated in the use of various MR imaging techniques, including magnetic resonance spectroscopy and functional MRI for diagnosis and disease progression in mood disorders, including bipolar disorder. It was during his graduate studies that he developed an interest in the field of neurodegeneration, regeneration and neuroprotection.

Dr. Seraji-Bozorgzad's research interest is primarily with non-invasive methods of monitoring disease progression in neurodegenerative disorders, with the ultimate goal of developing a tool set to monitor the efficacy of therapies early on in neurodegenerative disorders.

Vikram Shakkottai, MD, PhD - University of Michigan

Vikram Shakkottai, MBBS, PhD is an Associate Professor of Neurology. Dr. Shakkottai received his medical degree from the Christian Medical College, Vellore, India and a PhD in biological sciences at the University of California, Irvine. He received residency training in neurology at Washington University in Saint Louis and fellowship subspecialty training in movement disorders at the University of Michigan. Dr. Shakkottai cares for patients with all forms of movement disorders, but his clinical and research interests are focused on the cerebellar ataxias; he is Clinical Director of the Ataxia Program at the University of Michigan. Dr. Shakkottai’s research focuses on understanding the physiologic changes in the cerebellum that accompany cerebellar ataxia. He was awarded the the Leonard Berg award for research done as a neurology resident at Washington University.

Peter Tessier, PhD - University of Michigan

Peter Tessier is the Albert M. Mattocks Professor of Pharmaceutical Sciences and Chemical Engineering at the University of Michigan. The Tessier lab aims to develop next generation technologies for designing, discovering, engineering, characterizing, formulating and delivering biologics ranging from small affinity peptides to large monoclonal antibodies for molecular imaging, diagnostic and therapeutic applications. This interdisciplinary research program involves the use of experimental and computational approaches to generate new fundamental insights related to protein structure and function, molecular origins of protein-protein interactions, and sequence and structural determinants of key protein properties (stability, solubility, specificity and affinity). With an eye toward applications, the Tessier lab also develops novel high-throughput screening tools for discovering new biologics and identifying rare variants with drug-like properties for therapeutic applications.

Peter Todd, MD, PhD - University of Michigan

An Assistant Professor of Neurology and the Bucky and Patti Harris Collegiate Professor in Alzheimer’s disease at the University of Michigan, Dr. Todd explores the molecular mechanisms in neurodegenerative diseases with a particular interest in repeat expansion diseases such as the recently discovered C9ORF72 expansion underlying frontotemporal dementia. Dr. Todd is also a staff neurologist at the Ann Arbor VA Medical Center. He has worked in the field of Fragile X research for almost 20 years.

Jenna Wiens, PhD - University of Michigan

Dr. Wiens is an Assistant Professor in Computer Science Engineering (CSE) at the University of Michigan. She currently heads the MLD3 research group. Her primary research interests lie at the intersection of machine learning and healthcare. The overarching goal of her research agenda is to develop the computational methods needed to help organize, process, and transform data into actionable knowledge.